ReadCoor’s is a company developing a spatial sequencing platform, Fluorescent in situ Sequencing (FISSEQ), that produces readouts and 3D images for disease diagnosis. FISSEQ reads the sequences of molecules and visualizes 3D spatial information within whole cells and tissues, as well as delivers 3D coordinates for the full range of molecular targets across the panoramic spectrum, from DNA to therapeutic molecules.
|Employees (est.) (May 2020)||52||(+2%)|
ReadCoor total Funding
ReadCoor latest funding size
Time since last funding
|5 months ago|
|Decheng Capital, Vivo Capital, Chan Zuckerberg Initiative, Lilly Asia Ventures, Hansjörg Wyss, Pavilion Capital, Silicon Valley Community Foundation|
ReadCoor has 409 Twitter Followers. The number of followers has increased 1.3% month over month and increased 13.9% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was ReadCoor founded?
ReadCoor was founded in 2016.
Who are ReadCoor key executives?
ReadCoor's key executives are Lori Johnson, Richard Terry and Ben Linden.
How many employees does ReadCoor have?
ReadCoor has 52 employees.
Who are ReadCoor competitors?
Competitors of ReadCoor include Augment, SynVivo and BIOLIFE4D.
Where is ReadCoor headquarters?
ReadCoor headquarters is located at 840 Memorial Dr 5th flr, Cambridge.
Where are ReadCoor offices?
ReadCoor has an office in Cambridge.
How many offices does ReadCoor have?
ReadCoor has 1 office.
Receive alerts for 300+ data fields across thousands of companies